Marco Vitória

7.7k total citations · 1 hit paper
99 papers, 4.9k citations indexed

About

Marco Vitória is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marco Vitória has authored 99 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Infectious Diseases, 42 papers in Virology and 41 papers in Epidemiology. Recurrent topics in Marco Vitória's work include HIV/AIDS Research and Interventions (75 papers), HIV/AIDS drug development and treatment (47 papers) and HIV Research and Treatment (42 papers). Marco Vitória is often cited by papers focused on HIV/AIDS Research and Interventions (75 papers), HIV/AIDS drug development and treatment (47 papers) and HIV Research and Treatment (42 papers). Marco Vitória collaborates with scholars based in Switzerland, United States and United Kingdom. Marco Vitória's co-authors include Meg Doherty, Nathan Ford, Alexandra Calmy, Charles F. Gilks, Siobhan Crowley, Yves Souteyrand, Nathan Ford, Zara Shubber, Edward J. Mills and Reuben Granich and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Marco Vitória

95 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings

2006 510 citations Charles F. Gilks, Siobhan Crowley et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Vitória Switzerland	43	3.8k	1.8k	1.7k	708	576	99	4.9k
Cissy Kityo Uganda	38	4.5k 1.2×	2.8k 1.5×	1.6k 0.9×	735 1.0×	621 1.1×	202	5.6k
Andrew Kambugu Uganda	37	3.5k 0.9×	1.1k 0.6×	2.5k 1.4×	534 0.8×	690 1.2×	191	5.0k
Nathan Ford Switzerland	46	4.0k 1.0×	1.2k 0.7×	2.4k 1.4×	552 0.8×	888 1.5×	117	5.4k
François Venter South Africa	40	4.4k 1.2×	1.8k 1.0×	2.3k 1.3×	1.1k 1.6×	1.1k 1.8×	271	6.3k
Ian Sanne South Africa	48	5.3k 1.4×	2.1k 1.2×	3.0k 1.7×	859 1.2×	840 1.5×	186	6.7k
Mark J. Siedner United States	43	2.6k 0.7×	892 0.5×	1.4k 0.8×	950 1.3×	1.2k 2.0×	281	5.6k
Neil Martinson South Africa	40	4.3k 1.1×	866 0.5×	3.1k 1.8×	282 0.4×	569 1.0×	280	5.8k
Andrew Hill United Kingdom	43	4.8k 1.3×	3.1k 1.7×	1.8k 1.0×	1.2k 1.7×	185 0.3×	195	6.7k
Meg Doherty Switzerland	44	4.9k 1.3×	1.4k 0.8×	3.5k 2.1×	644 0.9×	1.1k 1.9×	121	6.8k
Judith Feinberg United States	43	5.0k 1.3×	3.3k 1.8×	3.2k 1.8×	1.2k 1.6×	351 0.6×	169	8.0k

Countries citing papers authored by Marco Vitória

Since Specialization

Citations

This map shows the geographic impact of Marco Vitória's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Vitória with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Vitória more than expected).

Fields of papers citing papers by Marco Vitória

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Vitória. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Vitória. The network helps show where Marco Vitória may publish in the future.

Co-authorship network of co-authors of Marco Vitória

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Vitória. A scholar is included among the top collaborators of Marco Vitória based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Vitória. Marco Vitória is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nutt, Cameron T., Richard Lessells, Winnie Muyindike, et al.. (2025). Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries With the Highest Adult HIV Prevalence. Clinical Infectious Diseases. 82(2). 265–273.

Easterbrook, Philippa, Nathan Ford, William L. Irving, et al.. (2024). Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 79(6). 1437–1446. 1 indexed citations

Vitória, Marco, et al.. (2023). COVID-19 e os sistemas de saúde do Brasil e do mundo: repercussões das condições de trabalho e de saúde dos profissionais de saúde. Ciência & Saúde Coletiva. 28(10). 2965–2978. 2 indexed citations

Vitória, Marco, et al.. (2023). COVID-19 and health systems in Brazil and around the world: effects on the working conditions and health of health workers. Ciência & Saúde Coletiva. 28(10). 2965–2978. 4 indexed citations

Grimsrud, Anna, Lynne Wilkinson, Sinéad Delany‐Moretlwe, et al.. (2023). The importance of the “how”: the case for differentiated service delivery of long‐acting and extended delivery regimens for HIV prevention and treatment. Journal of the International AIDS Society. 26(S2). e26095–e26095. 8 indexed citations

Wolff, Hans, François Chappuis, Pedro Albajar-Viñas, et al.. (2018). Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America. Journal of Tropical Medicine. 2018. 1–10. 9 indexed citations

Vitória, Marco, Andrew Hill, Nathan Ford, et al.. (2018). The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries. AIDS. 32(12). 1551–1561. 76 indexed citations

Rutstein, Sarah E., Jintanat Ananworanich, Sarah Fidler, et al.. (2017). Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. Journal of the International AIDS Society. 20(1). 21579–21579. 100 indexed citations

Ford, Nathan, Graeme Meintjes, Marco Vitória, Greg Greene, & Tom Chiller. (2017). The evolving role of CD4 cell counts in HIV care. Current Opinion in HIV and AIDS. 12(2). 123–128. 98 indexed citations

10.

Waldrop, Greer, Meg Doherty, Marco Vitória, & Nathan Ford. (2016). Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Tropical Medicine & International Health. 21(9). 1124–1130. 47 indexed citations

11.

Nsanzimana, Sabin, Eric Remera, Steve Kanters, et al.. (2015). Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study. The Lancet HIV. 2(9). e376–e384. 13 indexed citations

12.

Peeling, Rosanna Ŵ., Kimberly A. Sollis, Sarah Glover, et al.. (2015). CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy. PLoS ONE. 10(3). e0115019–e0115019. 25 indexed citations

13.

Ford, Nathan, Cadi Irvine, Zara Shubber, et al.. (2014). Adherence to HIV postexposure prophylaxis. AIDS. 28(18). 2721–2727. 64 indexed citations

14.

Sollis, Kimberly A., Pieter W. Smit, Susan A. Fiscus, et al.. (2014). Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples. PLoS ONE. 9(2). e85869–e85869. 44 indexed citations

15.

Ekouévi, Didier Koumavi, Boris Tchounga, Patrick Coffié, et al.. (2014). Antiretroviral therapy response among HIV-2 infected patients: a systematic review. BMC Infectious Diseases. 14(1). 461–461. 24 indexed citations

16.

Fuchs, Sandra Cristina Pereira Costa, Marina Beltrami Moreira, Bolanle Oyeledun, Papa Salif Sow, & Marco Vitória. (2013). HIV Infection and Cardiovascular Disease. The Scientific World JOURNAL. 2013(1). 156 indexed citations

17.

Ford, Nathan, Charles Flexner, Stefano Vella, David H. Brown Ripin, & Marco Vitória. (2013). Optimization and simplification of antiretroviral therapy for adults and children. Current Opinion in HIV and AIDS. 8(6). 591–599. 10 indexed citations

18.

Date, Anand, et al.. (2010). Aplicación de la profilaxis con cotrimoxazol y la terapia preventiva con isoniazida en los afectados por el VIH. Bulletin of the World Health Organization. 88(4). 241–241. 19 indexed citations

19.

Crowley, Siobhan, Nigel Rollins, Nathan Shaffer, et al.. (2009). New WHO HIV treatment and prevention guidelines. The Lancet. 375(9718). 874–875. 11 indexed citations

20.

Nguimfack, Boniface Dongmo, et al.. (2007). Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens. AIDS. 21(Suppl 4). S89–S95. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact